This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Nektar Therapeutics Class Action Lawsuit
Business class action lawsuit

Nektar Therapeutics Class Action Lawsuit

Analysis based on 30 articles · First reported Apr 07, 2026 · Last updated May 07, 2026

Sentiment
-70
Attention
4
Articles
30
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Nektar Therapeutics, alleging misleading statements about its REZOLVE-AA trial, has negatively impacted the company's stock price. This event highlights the risks associated with clinical trial integrity and corporate disclosures in the biotechnology sector, potentially leading to increased scrutiny from investors and regulators on similar companies.

Biotechnology Legal Services
Event Summary

Pomerantz LLP, Rosen Law Firm, and The Gross Law Firm have filed and are encouraging investors to join a class action lawsuit against Nektar Therapeutics. The lawsuit alleges that Nektar Therapeutics made materially false and misleading statements regarding its REZOLVE-AA trial for rezpegaldesleukin, a treatment for alopecia areata. Specifically, the company allegedly failed to disclose that enrollment in the trial did not follow applicable instructions and protocol standards, which negatively impacted the trial's results. When Nektar Therapeutics announced on December 16, 2025, that the trial failed to reach statistical significance, its stock price fell by 7.77%. The class period for the lawsuit is from February 26, 2025, to December 15, 2025, and the deadline for investors to seek lead plaintiff appointment is May 5, 2026.

Entities Involved
stock
Nektar Therapeutics
Nektar Therapeutics is the defendant in a class action lawsuit alleging misleading statements regarding its REZOLVE-AA trial, which led to a significant drop in its stock price.
Importance 100.0 Sentiment -70.0
priv
Pomerantz LLP
Importance 0.0 Sentiment 0.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
per
Danielle Peyton
Importance 0.0 Sentiment 0.0
govactor
United States — United States District Court for the Northern District of California
Importance 0.0 Sentiment 0.0
Relationships
Nektar Therapeutics related ↔ Rosen Law Firm
Nektar Therapeutics related ↔ Philip Kim
Nektar Therapeutics related ↔ Lawrence Rosen
Pomerantz LLP competitor ↔ Rosen Law Firm Pomerantz LLP is a direct competitor to Rosen Law Firm, with both firms frequently vying to represent shareholders as le
Pomerantz LLP related ↔ Philip Kim
Pomerantz LLP related ↔ Lawrence Rosen
Pomerantz LLP related ↔ Danielle Peyton
Pomerantz LLP related ↔ United States — United States District Court for the Northern District of California
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm related ↔ Danielle Peyton
Rosen Law Firm related ↔ United States — United States District Court for the Northern District of California
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
Philip Kim competitor ↔ Danielle Peyton Philip Kim, a partner at Rosen Law Firm, regularly competes for lead counsel status in securities class actions against
Philip Kim related ↔ United States — United States District Court for the Northern District of California
+ 3 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.